“It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty,” a spokesman added, saying it would depend on animal trials as to whether it could be considered “a promising candidate research vaccine” for Bundibugyo.
Trending
- Exploring Income Patterns with Python Pandas, Matplotlib, and Seaborn
- How to Fine-Tune LFM2 Using QLoRA and DPO: A Complete Step-by-Step Coding Tutorial on Google Colab
- Could lifting weights actually help you live longer?
- From Local App to Public Website in Minutes
- Anthropic IPO filing marks AI maturing into enterprise utility
- Tim’s Founder Kitchen — From Brainstorm to the President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics) (#868)
- TinyFish Launches BigSet: An Open-Source Multi-Agent System That Builds Structured Live Datasets from Plain-English Descriptions
- 'Why I'm showing my hernia online'
